NCT05989958: The Safety ,Tolerability and Efficacy Study of HepaCure in Chinese Subjects with Acute-On-Chronic Liver Failure
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 92 planned
- Started
- 22 Sep 2023
- Primary completion
- Sep 2026
- Arms
- HepaCure
- Results
- None posted
- 14 Aug 2023: Trial registered
- 22 Sep 2023: Trial started